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Abstract
A 69 year-old female was receiving renal replacement therapy (RRT) for acute renal
failure (ARF) in an intensive care unit (ICU). Consultation was requested from the palliative
medicine service to facilitate a shared decision-making process regarding goals of care.
Clinician responsibility in shared decision-making includes the formulation and
expression of a prognostic assessment providing the necessary perspective for a spokesperson
to match patient values with treatment options. For this patient, ARF requiring RRT in the ICU
was used as a focal point for preparing a prognostic assessment. A prognostic assessment
should include the outcomes of most importance to a discussion of goals of care: mortality risk
and survivor functional status, in this case including renal recovery. A systematic review of the
literature was conducted to document published data regarding these outcomes for adult patients
receiving RRT for ARF in the ICU. 41 studies met the inclusion criteria. The combined mean
values for short-term mortality, long-term mortality, renal-function recovery of short- term
survivors, and renal-function recovery of long-term survivors were 51.7%, 68.6%, 82.0%, and
88.4% respectively.
This case example illustrates a process for formulating and expressing a prognostic
assessment for an ICU patient requiring RRT for ARF. Data from the literature review provides
baseline information that requires adjustment to reflect specific patient circumstances. The
nature of the acute primary process, comorbidities, and severity of illness are key modifiers.
Finally, the prognostic assessment is expressed during a family meeting using recommended
principles of communication.
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Case Scenario
B.W., a 69-year-old female with a past medical history including hypertension, diabetes
mellitus, and surgical treatment for obesity was evaluated by the palliative medicine service on
the sixth day after admission to the intensive care unit (ICU). She had presented with an acute
ST-segment elevation myocardial infarction and was now

receiving mechanical ventilation

for cardiogenic pulmonary edema and suspected aspiration pneumonitis as well as multiple
vasoactive medication infusions to maintain adequate blood pressure. Continuous venovenous
hemodiafiltration (CVVHD) was initiated on the fourth hospital day because of anuria and a
progressive increase in serum creatinine. The patient was being medicated intermittently for
confusion and agitation. A non-contrast CT scan of the brain, hematolgic indices, and serum
bilirubin were normal.
Initial discussion with the patient’s husband, her designated surrogate decision-maker,
indicated a primary concern with the possibility of chronic dialysis. “She would never want that.”
The Palliative Care team considered how best to address this concern and provide an accurate
prognosis regarding the need for chronic dialysis given her current clinical condition.
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Introduction
Acute renal failure (ARF) is a common occurrence in patients likely to die in the ICU.1,2
ARF requiring renal replacement therapy (RRT) has been correlated with a significantly increased
mortality risk in critically ill ICU patients in a variety of clinical categories.3-5 As such, ARF
requiring RRT can provide a focal point for prognostic assessment by clinicians for this high-risk
group of ICU patients. For the family described in the case scenario, and many others, RRT
represents an important patient values and quality-of-life variable.6 The presence of ongoing
RRT, its imminent need, or likely possibility can prompt a discussion of the goals and plans for
management, including decisions to forego life-sustaining interventions. Palliative care is often
consulted to help families consider goals of care in this setting. However, there is little written
about how best to prognosticate on the need for long-term RRT in critically-ill patients as one
important factor in goals of care discussions. This paper will help to address this absence in the
literature.
As Palliative Care providers, we know that shared decision-making is the preferred model
for interacting with families of incapacitated critically ill patients.7,8 A key component of our
responsibility in the shared decision-making process is to prognosticate – to effectively
communicate information about the expectations for positive or negative outcomes with different
management goals and plans.9 Prognostic assessment by the clinical team is essential in
enabling the family to frame their decisions in the context of patient values. Prognostication and
shared decision-making in this setting is extremely challenging. The medical information that we
provide based on a review of the literature should be counterbalanced by the inherent uncertainty
of predicting the course of events for a given patient situation. Moreover, an estimate of mortality
risk needs to be combined with a discussion of the projected functional and quality of life
implications of the acute illness IF short term survival is achieved. Oftentimes, it is difficult to
predict long-term outcomes such as the need for RRT when the short-term outcome is so
uncertain.
To describe the process of formulating and expressing a prognostic assessment for the
patient described in the introductory scenario, ARF requiring RRT in the ICU will be used as a
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central feature of the patient’s condition to focus the necessary research and analysis. A
sequence of three steps for the formulation and expression of a prognostic assessment will be
discussed in this paper. First, we will provide a literature review of outcomes most relevant to
family decision-makers. Second, we will incorporate this data with other clinical variables to
arrive at a meaningful prognostic assessment for this individual patient. Finally, we will
recommend an approach to communicate this prognostic assessment in an understandable and
accurate manner that fosters shared decision-making with the family.10
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Literature Review: Outcome of Acute Renal Failure requiring Renal Replacement Therapy
in the Intensive Care Unit
Methods
We systematically searched the literature for articles published between January 1, 2000
and June 1, 2010 providing absolute number data on mortality and renal recovery of patients
receiving RRT for ARF in the ICU. The search was initiated in PubMed using MeSH terms “Acute
Renal Failure” or “Acute Kidney Failure” and “Renal Replacement Therapy” or “Renal Dialysis”
and “Intensive Care Units” or “Critical Illness” and “Outcome Assessment (Health Care)” or
“Epidemiology.” Additional electronic databases (Ovid/Medline and EMBASE) were searched
using keywords acute renal failure, acute kidney injury, renal replacement therapy, dialysis,
critical illness, and intensive care units. Also searched were the websites of major journals likely
to publish articles relevant to our topic: Critical Care Medicine; Intensive Care Medicine; American
Journal of Respiratory and Critical Care Medicine; Journal of the American Society of
Nephrology; Nephrology, Dialysis, and Transplantation; and American Journal of Kidney
Diseases. In addition, bibliographies of papers that potentially met our criteria were reviewed for
further references.
Studies published in English between 2000 and 2010 were included in this analysis if
they met the following criteria: (1) patients greater than 18 years old, (2) patients received renal
replacement therapy for acute renal failure in an intensive care unit, (3) outcome reported as
mortality and recovery or not of renal function defined as independence or not from renal
replacement therapy at a specified time interval or intervals starting with the intensive care unit
stay, (4) patients with identified pre-existing renal dysfunction excluded, (5) patients with heart,
liver, lung, or kidney transplants not included.
Results
41 articles meeting the inclusion criteria were identified (Table 1). 25 studies reported
short-term (ICU discharge, hospital discharge, or up to 30 days) outcome on a total of 4765
patients. Mean short-term mortality was 54.8%. 83% of the short-term survivors were no longer
receiving renal replacement therapy. 9 papers provided long-term outcome data on 4797
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patients. A mean of 62.1% of these patients died during long-term follow-up ranging from 3
months to 5 years after hospital discharge. At the time of data collection a mean of 91.5% of the
survivors in these long-term reports were not receiving renal replacement therapy. Finally, 7
studies reported both short- and long-term outcome in the same group of patients. In the
combined 2290 patients reported in these papers, the mean values for short-term mortality, longterm mortality, renal-function recovery of short- term survivors, and renal-function recovery of
long-term survivors were 45.8%, 51.8%, 86.8%, and 94.3% respectively.
In the 32 studies reporting short-term mortality, the median value was 51.1% with an
upper quartile of 60.3% to 80.6%. 16 of the studies reported long-term mortality. The median
mortality in these investigations was 67.9% with an upper quartile of 85.3% to 87.7%. The mean
long-term follow-up interval was 15.7 months and median 6 months.
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Formulating the Prognostic Assessment
Formulating a prognostic assessment for the patient in the introductory case scenario to
aid in shared decision-making begins with the summary statistics from the literature review.
However, prognostication for this patient becomes more challenging when her specific
circumstances are reviewed. The primary acute diagnosis and the severity and extent of
important comorbid conditions influence short- and long-term mortality and determine the
functional status and quality of life of survivors.51 Severity of the acute illness as assessed by the
extent of organs systems dysfunction is the primary determinant of short-term mortality.52 A
general principle is that, with the exception of some patients in the ICU after planned surgical
procedures, the functional status and quality of life for ICU survivors will not exceed their premorbid condition.53 In all likelihood, the health-related status will be worse.
The patient presented in the introductory case scenario was receiving RRT for ARF in the
ICU. Based on this information alone the estimated short- and long-term mortalities would be
50% and 60% respectively. 90% of survivors would be expected to be free of long-term RRT.
However, she presented with a primary diagnosis of acute myocardial infarction and had multiple
subsequent complications including, but not limited to, ARF. Whether the patient could recover to
the point where additional interventions to retrieve myocardial function and reduce short- and
long-term mortality risk of this serious primary process was doubtful. Short-term survival would
likely be associated with health-related functional and quality of life limitations related to heart
failure. Sepsis related to aspiration pneumonitis was an acute comorbid event predicted to
negatively affect outcomes54 in addition to the risk associated with delirium.55 Overt failure of the
circulatory, respiratory, and renal organ-systems function identified a high severity of illness,
justifying a modification of the short-term mortality estimate to the higher frequencies of those
reported in the literature review.56 Moreover, she had significant chronic comorbid conditions
such as hypertension, diabetes mellitus, and obesity that were likely to adversely influence the
short-term and, to a greater extent, long-term mortality as well as survivor function and quality of
life. Finally, age is a necessary but not primary consideration in discussions for decision-making

Acute Renal Failure in the Intensive Care Unit

9

in the ICU. The scenario patient was in an age group associated with higher risk of adverse
outcomes.57
The preceding analysis of patient-specific factors (acute disease process, comorbidities,
and severity of illness) leads to a revision of original estimates based on the starting point of the
risks faced by any patient receiving RRT for ARF in the ICU. For the purpose of formulating a
prognostic assessment regarding the scenario patient, the short- and long-term mortality
estimates would be 75-80% and 85-90% respectively. Short- or long-term survival would have a
relatively low likelihood of requiring chronic RRT. However, because of the previously mentioned
acute and preexisting comorbidities other health-related limitations of function and quality of life
would be anticipated. The most optimistic outcome prediction of returning home with some
independent function would include significant time and resource investments for convalescence
and rehabilitation. These would be necessary to bridge immediate post ICU survival to the
possible resumption of an independent existence outside of an institutional setting.
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Communicating the Prognostic Assessment
Palliative Care clinicians are often asked to help communicate prognostic information in a
way that will foster shared decision-making with families of critically ill patients. The challenge of
these types of discussions is providing accurate prognostic information in the context of medical
uncertainty. How should we express the likely outcomes for a patient like Mrs. W when the
prognosis is affected by a multiple factors associated with that individual’s clinical case? How
should we respond to her husband’s statement about long-term RRT when the RRT is just a
small part of the prognostic picture?
We know that most families of incapacitated ICU patients wish to receive prognostic
estimates about the condition of their loved one.58 Moreover, avoiding a straightforward
discussion of prognosis with family members of an incapacitated ICU patient because of
uncertainty about the prognosis or concern for extinguishing hope is misguided.59 Prognostic
information allows the designated surrogate decision-maker and other family members to
participate in shared decision-making and help them prepare emotionally and logistically for a
fatal or significantly adverse outcome.60 In addition, a carefully considered and communicated
prognostic assessment assists the family in reframing the concept of hope while dealing with a
life-threatening illness.61 It has been demonstrated that family members generally recognize the
inherent uncertainty of medical predictions while still highly valuing discussions about prognosis.62
Although a discussion of how to conduct effective family meetings to foster shared
decision-making is beyond the scope of this paper, certain specific strategies can be
recommended for delivering the prognostic assessment within a broader conversation regarding
patient and family values and goals. Initial discussions with Mr. W should assess his
understanding of his wife’s illness including her prognosis as well as address the type of
information he wishes to receive, in what form, and important components of medical decisionmaking for him.7 His prognostic understanding will likely come from many sources, not just
medical input from physicians.63 Exploration of his comment “She would not want that” is
warranted to further understand his distress and its impact on future medical decisions.
A brief opening statement by the health care provider facilitating the meeting, a “warning
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shot”, sets a tone for the subsequent discussion regarding prognosis: 64
.….” All of the people caring for Mrs. W are doing their best to improve her condition.
However, she is not responding as we would hope and remains critically ill. This means
that she is at significant risk of dying despite our best efforts to save her”…..
If, during prior discussions, Mr. W was inclined toward numeric probabilities as a means
to consider his wife’s possible illness trajectories, expressions of mortality risk are recommended
but should be expressed as natural frequencies and framed as outcomes for populations rather
than individuals: 65
…..”Unfortunately I cannot predict for you exactly what is going to happen. I will give you
the best prediction I can based on prior studies and our own experience and judgment. If
we were to look at 100 people in Mrs. W’s condition about 75-80 of them would not
survive to leave the hospital. Of the people who survived, more would predictably die
within 1-2 years; by that time about 90 of the original 100 would be dead. …….to
address the concern you mentioned yesterday, Mr. W, only 2 or 3 out of 10 – of those
able to survive – would need to be on dialysis long-term”…..
Incorporating the possibility of short-term survival, predictions regarding functional
outcomes such as health-related quality of life, need for ongoing life support measures, and
disposition locations should be included in addition to an acknowledgement of the uncertain
outcome: 58
….. “If she survives, her heart would be weakened and this – along with her other health
problems before this one – would cause limits to her ability to function and enjoy life. I
would anticipate the need for a significant period of time in a nursing home to receive 24
hour care. There is no way at the present time to know what the result of this would be
but it is highly unlikely that she will return home like she was before”…..
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Conclusion
A shared decision-making process offers the best opportunity to respect patient
autonomy while optimizing medical care for incapacitated ICU patients. Family meetings provide
a forum for this process to occur. It is the responsibility of the healthcare provider facilitating a
family meeting to provide a well formulated and effectively communicated prognostic assessment.
There are limitations to the application of the literature review reported here to
formulating a prognostic assessment. The studies analyzed present data from a heterogeneous
group of patients receiving different forms of RRT. This allows the accumulation of a sizeable
sample and a statement of a general outcome trend with some confidence but limits the ability to
accurately predict outcome for an individual patient. Many of the studies in the literature review
reported data from the experimental groups in controlled investigations of issues such as the
timing, technique, and technology of the administration of RRT. These issues are of great
importance in promoting the best possible outcomes for ARF patients receiving RRT. However,
current reviews of this topic do not indicate an ability to predict a better or worse outcome based
on specific factors such as timing, intensity or mode of RRT.2 The majority of patients in ICUs at
the present time will be receiving a continuous RRT technique with a biocompatible membrane.66
For the purpose of formulating and expressing a prognostic assessment as part of shared
decision-making for an incapacitated ICU patient the data presented in the preceding literature
review represents a baseline that must be integrated with other patient-specific considerations.
Acute renal failure (ARF) requiring renal replacement therapy (RRT) provides a focal
point for developing a prognostic assessment for a critically ill patient with multiple organ-system
failure. Combining historical data from a literature review with clinical judgment regarding the
effects on outcome of comorbidities and severity of acute illness is recommended as an approach
to formulating the prognostic assessment. Attention to key principles of communication in shared
decision-making enables effective expression of the prognostic assessment to the family.
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